Indegene posted a strong 39.5% year-on-year revenue increase to Rs 1,122.3 crore for Q2 FY27. Despite the financial growth, the company announced the resignation of a non-executive director and its company secretary. Shareholders should watch for the impact of these management changes and the ongoing status of the TCPA class action settlement.
Indegene Reports Q2 Profit of Rs 112.3 Crore
Revenue Soars to Rs 1,122.3 Crore, Up 39.5% YoY
Reader Takeaway: Strong top-line growth is tempered by management churn and lingering class action litigation risks.
What just happened
Indegene Limited released its Q2 FY27 results, reporting a consolidated revenue from operations of Rs 1,122.3 crore, compared to Rs 804.2 crore in the same period last year. Profit for the period stands at Rs 112.3 crore, up from Rs 102.1 crore in Q2 FY26. Beyond the financials, the company’s board approved the resignation of Non-Executive Non-Independent Director Mr. Mark Francis Dzialga and Company Secretary Ms. Srishti Ramesh Kaushik.
Why this matters
The significant 39.5% year-on-year revenue growth signals robust business health and successful scaling of services. However, the concurrent exit of a director—linked to the stake sale by Brighton Park Capital—and the company secretary introduces a period of leadership transition that investors should monitor closely for continuity.
Risks to watch
The ongoing TCPA class action lawsuit remains a focal point. While the company maintains that existing provisions are sufficient, the legal process will continue until the claims submission deadline in December 2026. Governance-focused investors will also track the impact of the newly reconstituted Nomination and Remuneration Committee.
What to track next
The trading window for designated persons will reopen on November 2, 2026. Further updates regarding the appointment of a new company secretary and potential shifts in corporate strategy following the departure of Brighton Park Capital representatives will be key indicators for the coming quarters.